{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T06:08:22Z","timestamp":1780985302521,"version":"3.54.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T00:00:00Z","timestamp":1611532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002997","name":"Nierstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002997","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017490","name":"Unilever Research and Development Vlaardingen B.V.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017490","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018722","name":"Jaap Schouten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.numecd.2021.01.012","type":"journal-article","created":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T01:42:13Z","timestamp":1611884533000},"page":"1467-1476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Plasma fatty acids and kidney function decline in post-myocardial infarction patients of the Alpha Omega Cohort"],"prefix":"10.1016","volume":"31","author":[{"given":"Anniek C.","family":"van Westing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8844-6784","authenticated-orcid":false,"given":"Marion R.","family":"Eckl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne K.","family":"K\u00fcpers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamalita","family":"Pertiwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5482-2013","authenticated-orcid":false,"given":"Ellen K.","family":"Hoogeveen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7638-0589","authenticated-orcid":false,"given":"Johanna.M.","family":"Geleijnse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2021.01.012_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.kint.2018.04.011","article-title":"Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016","volume":"94","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2021.01.012_bib2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2471\/BLT.17.206441","article-title":"The global burden of kidney disease and the sustainable development goals","volume":"96","author":"Luyckx","year":"2018","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.numecd.2021.01.012_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2021.01.012_bib4","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from Kidney Disease: improving Global Outcomes (KDIGO)","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.numecd.2021.01.012_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0129036","article-title":"Longitudinal study of the decline in renal function in healthy subjects","volume":"10","author":"Baba","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.numecd.2021.01.012_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.ajkd.2013.01.019","article-title":"Racial differences in estimated GFR decline, ESRD, and mortality in an integrated health System stephen","volume":"62","author":"Derose","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.numecd.2021.01.012_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2007.02.047","article-title":"Effect of first myocardial ischemic event on renal function","volume":"100","author":"Eijkelkamp","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2021.01.012_bib8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/2047487317739986","article-title":"Body-fat indicators and kidney function decline in older post-myocardial infarction patients: the Alpha Omega Cohort Study","volume":"25","author":"Esmeijer","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/j.numecd.2021.01.012_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.ekir.2018.03.005","article-title":"Cardiovascular risk factors accelerate kidney function decline in post\u2212myocardial infarction patients: the Alpha Omega Cohort Study","volume":"3","author":"Esmeijer","year":"2018","journal-title":"Kidney Int Reports"},{"key":"10.1016\/j.numecd.2021.01.012_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0171868","article-title":"Kidney function and specific mortality in 60-80 years old post-myocardial infarction patients: a 10-year follow-up study","volume":"12","author":"Hoogeveen","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.numecd.2021.01.012_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12944-020-01258-y","article-title":"The C18:3n6\/C22:4n6 ratio is a good lipid marker of chronic kidney disease (CKD) progression","volume":"19","author":"Szczuko","year":"2020","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.numecd.2021.01.012_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/nu10101353","article-title":"Blood fatty acid status and clinical outcomes in dialysis patients: a systematic review","volume":"10","author":"Khor","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/j.numecd.2021.01.012_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.clnu.2013.03.001","article-title":"Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease","volume":"33","author":"Mayneris-Perxachs","year":"2014","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-8587(17)30307-8","article-title":"Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39\u2008740 adults from 20 prospective cohort studies","volume":"5","author":"Wu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.numecd.2021.01.012_bib15","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1001\/jamainternmed.2016.2925","article-title":"\u03c9-3 polyunsaturated fatty acid biomarkers and coronary heart disease: pooling project of 19 cohort studies","volume":"176","author":"Del Gobbo","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.numecd.2021.01.012_bib16","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013131","article-title":"Circulating fatty acids and risk of coronary heart disease and stroke: individual participant data meta-analysis in up to 16 126 participants","volume":"9","author":"Borges","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2021.01.012_bib17","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M13-1788","article-title":"Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis","volume":"160","author":"Chowdhury","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2021.01.012_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002094","article-title":"Association of plasma phospholipid n-3 and n-6 polyunsaturated fatty acids with type 2 diabetes: the EPIC-InterAct case-cohort study","volume":"13","author":"Forouhi","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.numecd.2021.01.012_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21041362","article-title":"Marine omega-3 (N-3) fatty acids for cardiovascular health: an update for 2020","volume":"21","author":"Innes","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2021.01.012_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pmed.1002670","article-title":"Fatty acid biomarkers of dairy fat consumption and incidence of type 2 diabetes: a pooled analysis of prospective cohort studies","volume":"15","author":"Imamura","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/j.numecd.2021.01.012_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/MOL.0000000000000381","article-title":"Milk fat biomarkers and cardiometabolic disease","volume":"28","author":"Ris\u00e9rus","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.numecd.2021.01.012_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/JAHA.113.000092","article-title":"Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis","volume":"2","author":"de Oliveira Otto","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.numecd.2021.01.012_bib23","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-018-0724-z","article-title":"Dairy products, dairy fatty acids, and the prevention of cardiometabolic disease: a review of recent evidence","volume":"20","author":"Yu","year":"2018","journal-title":"Curr Atherosclerosis Rep"},{"key":"10.1016\/j.numecd.2021.01.012_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.ejcn.1602307","article-title":"Intake of milk fat, reflected in adipose tissue fatty acids and risk of myocardial infarction: a case-control study","volume":"60","author":"Biong","year":"2006","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib25","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1373\/clinchem.2007.095521","article-title":"Plasma polyunsaturated fatty acids and the decline of renal function","volume":"54","author":"Lauretani","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2021.01.012_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.plipres.2008.03.003","article-title":"Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake","volume":"47","author":"Hodson","year":"2008","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.numecd.2021.01.012_bib27","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3945\/ajcn.114.083097","article-title":"Circulating biomarkers of dairy fat and incident type 2 diabetes in two us prospective cohorts","volume":"100","author":"Yakoob","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib28","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1161\/CIRCULATIONAHA.115.018410","article-title":"Circulating biomarkers of dairy fat and risk of incident diabetes mellitus among US men and women in two large prospective cohorts","volume":"133","author":"Yakoob","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2021.01.012_bib29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.numecd.2018.12.010","article-title":"Circulating n-3 fatty acids and linoleic acid as indicators of dietary fatty acid intake in post-myocardial infarction patients","volume":"29","author":"Pertiwi","year":"2019","journal-title":"Nutr Metabol Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2021.01.012_bib30","doi-asserted-by":"crossref","first-page":"358","DOI":"10.2337\/dc19-1483","article-title":"Plasma and dietary linoleic acid and 3-year risk of type 2 diabetes after myocardial infarction: a prospective analysis in the Alpha Omega Cohort","volume":"43","author":"Pertiwi","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2021.01.012_bib31","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/ajcn\/82.6.1178","article-title":"Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents","volume":"82","author":"Klein-Platat","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib32","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00394-015-0911-4","article-title":"Longitudinal associations of serum fatty acid composition with type 2 diabetes risk and markers of insulin secretion and sensitivity in the Finnish Diabetes Prevention Study","volume":"55","author":"Takkunen","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12937-018-0342-1","article-title":"Association between plasma fatty acids and inflammatory markers in patients with and without insulin resistance and in secondary prevention of cardiovascular disease, a cross-sectional study","volume":"17","author":"Bersch-Ferreira","year":"2018","journal-title":"Nutr J"},{"key":"10.1016\/j.numecd.2021.01.012_bib34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.clnu.2016.11.006","article-title":"Changes in plasma fatty acid composition are associated with improvements in obesity and related metabolic disorders: a therapeutic approach to overweight adolescents","volume":"37","author":"Guerendiain","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib35","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ahj.2009.12.033","article-title":"Effect of low doses of n-3 fatty acids on cardiovascular diseases in 4,837 post-myocardial infarction patients: design and baseline characteristics of the Alpha Omega Trial","volume":"159","author":"Geleijnse","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2021.01.012_bib36","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1056\/NEJMoa1003603","article-title":"N-3 fatty acids and cardiovascular events after myocardial infarction","volume":"363","author":"Kromhout","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.01.012_bib37","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1373\/49.4.652","article-title":"High stability of markers of cardiovascular risk in blood samples","volume":"49","author":"Giltay","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.numecd.2021.01.012_bib38","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.01.012_bib39","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2021.01.012_bib40","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.2215\/CJN.10441013","article-title":"Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial","volume":"9","author":"Hoogeveen","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.numecd.2021.01.012_bib41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/ajcn\/58.4.489","article-title":"Relative and biomarker based validity of a food-frequency questionnaire estimating intake of fats and cholesterol","volume":"58","author":"Feunekes","year":"1993","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib42","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/09637489509012539","article-title":"Reproducibility of a semiquantitative food frequency questionnaire to assess the intake of fats and cholesterol in The Netherlands","volume":"46","author":"Feunekes","year":"1995","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.numecd.2021.01.012_bib43","series-title":"Anatomical therapeutic chemical classification system (ATC)","author":"Who Collaborating Centre for Drug Statistics Methodology","year":"2009"},{"key":"10.1016\/j.numecd.2021.01.012_bib44","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/aje\/kwi187","article-title":"When is baseline adjustment useful in analyses of change? An example with education and cognitive change","volume":"162","author":"Glymour","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.numecd.2021.01.012_bib45","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.lfs.2018.04.049","article-title":"Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance \u2014 a review","volume":"203","author":"Saini","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.numecd.2021.01.012_bib46","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/CIRCULATIONAHA.118.038908","article-title":"Biomarkers of dietary omega-6 fatty acids and incident cardiovascular disease and mortality: an individual-level pooled analysis of 30 cohort studies","volume":"139","author":"Marklund","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2021.01.012_bib47","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/obr.12280","article-title":"Long-chain polyunsaturated fatty acid status in obesity: a systematic review and meta-analysis","volume":"16","author":"Fekete","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/j.numecd.2021.01.012_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms17040562","article-title":"NAFLD and chronic kidney disease","volume":"17","author":"Marcuccilli","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.numecd.2021.01.012_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11906-020-1020-1","article-title":"Diet and kidney function: a literature review","volume":"22","author":"van Westing","year":"2020","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.numecd.2021.01.012_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nut.2018.03.047","article-title":"Dairy products and chronic kidney disease: protective or harmful? A systematic review of prospective cohort studies","volume":"55\u201356","author":"Eslami","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/j.numecd.2021.01.012_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12986-019-0407-y","article-title":"Associations of dairy and fiber intake with circulating odd-chain fatty acids in post-myocardial infarction patients","volume":"16","author":"Pertiwi","year":"2019","journal-title":"Nutr Metab"},{"key":"10.1016\/j.numecd.2021.01.012_bib52","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1080\/1354750X.2019.1583770","article-title":"Circulating fatty acids as biomarkers of dairy fat intake: data from the lifelines biobank and cohort study","volume":"24","author":"Pranger","year":"2019","journal-title":"Biomarkers"},{"key":"10.1016\/j.numecd.2021.01.012_bib53","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4314\/gmj.v50i3.11","article-title":"Coconut oil and palm oil's role in nutrition, health and national development: a review","volume":"50","author":"Boateng","year":"2016","journal-title":"Ghana Med J"},{"key":"10.1016\/j.numecd.2021.01.012_bib54","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3945\/ajcn.112.045468","article-title":"Trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"97","author":"Mozaffarian","year":"2013","journal-title":"Am J Clin Nutr"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321000326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475321000326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:18:12Z","timestamp":1760545092000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475321000326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0939475321000326"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2021.01.012","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma fatty acids and kidney function decline in post-myocardial infarction patients of the Alpha Omega Cohort","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2021.01.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}]}}